etravirine has been researched along with propantheline in 2 studies
| Studies (etravirine) | Trials (etravirine) | Recent Studies (post-2010) (etravirine) | Studies (propantheline) | Trials (propantheline) | Recent Studies (post-2010) (propantheline) |
|---|---|---|---|---|---|
| 572 | 90 | 321 | 598 | 94 | 28 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Daelemans, D; De Clercq, E; Huang, B; Kang, D; Liu, X; Pannecouque, C; Tian, Y; Zhan, P; Zhou, Z | 1 |
1 review(s) available for etravirine and propantheline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for etravirine and propantheline
| Article | Year |
|---|---|
First discovery of a potential carbonate prodrug of NNRTI drug candidate RDEA427 with submicromolar inhibitory activity against HIV-1 K103N/Y181C double mutant strain.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cell Line, Tumor; Cyclopropanes; HIV Reverse Transcriptase; HIV-1; Humans; Hydrolysis; Mutation; Nevirapine; Nitriles; Prodrugs; Pyridazines; Pyrimidines; Pyrroles; Reverse Transcriptase Inhibitors | 2018 |